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Abstract
Eleven polybrominated diphenyl ether (tri- to deca-BDE) congeners and 2,2′,4,4′,5,5′-
hexabromobiphenyl (BB153) have been measured in pooled serum samples from the National 
Health and Nutrition Examination Survey (NHANES) for one decade (from survey years 2005/06 
through 2013/14). The pools, which are representative of the general noninstitutionalized 
population of the United States, encompassed thirty-two demographic groups defined by sex, race/
ethnicity (Mexican American, non-Hispanic black, non-Hispanic white, and all other race/
ethnicities), and age (12–19, >20–39, >40–59, and ≥60 years). The adjusted geometric means were 
determined in a multiple linear regression model for the six congeners (BDE28, BDE47, BDE99, 
BDE100, BDE153, and BB153) with detectable concentrations in at least 60% of pools in each of 
the thirty-two demographic groups; the level of significance for all statistical comparisons thereof 
were determined. BDE154 and BDE209 were detected in 60% of the NHANES 2011/12 and 
2013/14 pools; only these two survey periods were evaluated for these congeners. The percent 
change in concentration by a 2-year survey period was calculated. All examined PBDEs reported 
in five survey periods decreased in concentration, except BDE153, for which concentrations 
increased by 12.0% (95% CI 7.1–16.4) and 8.4% (95% CI 2.9–14.1) for the age groups 40–59 and 
≥60 years, respectively; no significant change was observed in younger age groups. Excluding 
BDE153, we observed larger percentage decreases by a 2-year survey period for the age groups 
12–19, 20–39, and ≥60 years compared with the age group 40−59 years. The percentage decrease 
by a two-year survey period ranged between −19.6% (BDE99, 20–39 years old) and −4.5% 
(BDE100, 40−59 years old). Although five polybrominated diphenyl ether (PDBE) congeners and 
BB153 are still frequently detected in the U.S. general population, PBDE concentrations have 
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decreased since 2005–2006, likely, because of changes in manufacturing practices that started in 
the mid-2000s.
Graphical Abstract
INTRODUCTION
Polybrominated diphenyl ethers (PBDEs), used as flame retardants in consumer products 
and vehicles (e.g., cars, airplanes), were produced in three commercial mixtures defined by 
their average bromination degree, e.g., PentaBDE, OctaBDE, and DecaBDE.1 PentaBDE 
was used as a flame retardant in polyurethane in applications such as furniture, seat cushions 
in vehicles, and in the polyurethane pads used under wall-to-wall carpets. The higher 
bromination degree products (Octa- and DecaBDE) were primarily used, among other 
applications, in hard plastics, including the casing for electrical appliances. Penta- and 
OctaBDE were withdrawn from the U.S. market in 2004, while commercial production of 
DecaBDE was discontinued in 2013, and any new imports of DecaBDE after 2013 would be 
subjected to significant new use reporting.2
The major exposure routes for PBDEs were diet and ingestion of residential dust with dust 
ingestion commonly considered to be most relevant.3–6 Dietary ingestion includes 
consumption of fatty fish and other foods of animal origin, such as meat and poultry.7 Diet is 
the dominating route of exposure for other persistent organic pollutants (POPs), such as 
polychlorinated biphenyls (PCBs), organochlorine pesticides, and polychlorinated dibenzo-
p-dioxins and furans (PCDD/F), for the U.S. general population not occupationally exposed 
to these compounds. As time passes from the withdrawal of PBDEs from the U.S. market, 
and PBDEs are removed from the indoor environment by the replacement of furniture and 
consumer articles, dietary exposures are likely to become a more important route of human 
exposure.
The National Health and Nutrition Examination Survey (NHANES), administrated by the 
Centers for Disease Control and Prevention (CDC), provides an ongoing exposure 
assessment of the general noninstitutionalized population of the United States with respect 
to environmental pollutants and nutritional biomarkers by demographic characteristics, such 
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as age, sex, and race/ethnicity. One important objective of the NHANES biomonitoring 
program is to capture changes in chemical exposure (concentration in biological fluid, e.g., 
serum and/or urine), resulting from regulatory interventions, and changes in usage patterns 
related to human behavior and/or replacement chemicals reaching the market place. The 
National Reports on Human Exposure to Environmental Chemicals, which summarize the 
NHANES biomonitoring data,8 include results on POPs, such as PCBs, organochlorine 
pesticides, PCDD/F, and PBDEs.
We report the changes in concentration of select PBDEs in NHANES serum pools 
representative of the general non- institutionalized U.S. population covering a decade (from 
2005/06 through 2013/14).
MATERIALS AND METHODS
The CDC conducted NHANES continuously since 1999 (with biannual data releases) to 
assess the health and nutrition status of the civilian noninstitutional population.8 The 
NHANES includes a physical examination, household interviews, collection of medical 
history, and serum and urine samples for measurement of clinical, environmental, and 
nutritional biomarkers.8 Presented here are PBDEs and 2,2′,4,4′,5,5′- hexabromobiphenyl 
(BB153) measurements conducted on serum pools prepared by using individual sera 
collected from a one-third subset of all survey participants over the age of 12 years with a 
serum sample that had a sufficient volume for laboratory testing for NHANES 2005/06, 
2007/08, 2009/10, 2011/12, and 2013/14. The Research Ethics Review Board of the 
National Center for Health Statistics (NCHS) reviewed and approved the study protocol. All 
participants gave informed written consent, and parents or guardians provided assent for 
participants younger than 18 years of age.
NHANES Sampling Weights.
The NHANES is a multistage, probability sampling survey. Oversampling of certain 
population subgroups was performed to increase the reliability and precision of estimates. 
Sampling weights were adjusted for unequal selection probability and were used to produce 
properly weighted population estimates of means, percentiles, and other descriptive 
statistics. The sample weights were determined by NCHS as follows. Nonpublic “base 
sample weights” were assigned to all persons solicited to participate in the survey and later 
adjusted for (1) nonresponse for interview and/or examination and (2) nonresponse for 
biological sampling. Subjects were selected from an approximately one- third subset of 
survey participants with a serum sample that had a sufficient volume for laboratory testing 
and were then assigned a subsample weight.
Pooling Strategy.
The pooling strategy was based on demographic groups that were defined by the cross 
classification of (1) sex (female and male), (2) age group (12–19, 20–39, 40–59, and ≥60 
years), and (3) race/ethnicity. For NHANES 2005/06 and 2007/08, race/ethnicity groups 
were defined as Mexican American (MA), non- Hispanic black (NHB), non-Hispanic white 
(NHW), and all others (OTHER). For NHANES 2009/10, race/ethnicity was defined as MA, 
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NHB, NHW, other Hispanic (OH), and OTHER. NHANES 2011/12 and 2013/14 used the 
same grouping scheme as 2009/10, except that “OTHER” was divided further into non-
Hispanic Asian (NHA) and the remaining. Thus, sample pooling was based on four race/
ethnicity groups of MA, NHB, NHW, and OTHER (comprised of all race/ethnicity other 
than MA, NHB, and NHW).
The total number of available individual serum samples was 1973 (NHANES 2005/06), 
2070 (NHANES 2007/09), 2322 (NHANES 2009/10), 1940 (NHANES 2011/12), and 2179 
(NHANES 2013/14). These samples were used to create 247 (NHANES 2005/06), 264 
(NHANES 2007/09), 301 (NHANES 2009/10), 251 (NHANES 2011/12), and 284 
(NHANES 2013/14) serum pools, each comprised of eight individual samples. The number 
of pools created for each demographic group varied depending on the available number of 
individual samples (Supporting Information, Table S1).
We then assigned individual samples to pools using a SAS program (SAS 9.4; SAS Institute 
Inc., Cary, NC) to merge the (1) data file containing subsample weights, (2) data file 
containing demographic information, and (3) file containing the available serum volume by 
sample. The resulting data file was sorted by group and by the inverse subsample weight. A 
target of eight samples per pool was chosen based on the results of simulation experiments.9 
Then, for each demo- graphic group, the program assigned the first eight samples to the first 
pool, the next eight samples to the second pool, and so on until all samples were assigned to 
pools or until an insufficient number of serum samples were available to create additional 
pools. Thereafter, the program created a new variable, equal to the subsample weight of an 
individual sample divided by the sum of subsample weights of all samples in the 
corresponding pool, to calculate the proportional amount of each sample to be added to a 
pool so that the added volume was directly proportional to the subsample weight. The 
desired volume of each pool was 40 g; the program flagged any samples with insufficient 
available volume to meet the proportional volume requirement. The process was repeated 
after removal of flagged samples until no sample included in a pool had an insufficient 
volume. Measurements of pools created in this way are mathematically equal to weighted 
arithmetic means of the samples in the pools in keeping with the NHANES weighted 
sampling design, so that the estimates are representative of the general noninstitutionalized 
U.S. population.
Preparation of the Serum Pools.
The individual serum samples were thawed and mixed before the desired serum amounts 
were weighed into 60 mL Qorpak borosilicate glass bottles with Teflon PTFE-lined 
polypropylene screw caps (Qorpak, Bridgeville, PA). These vials were cleaned in a 
laboratory dish washer and heated overnight to 300 °C, and the caps were Soxhlet-extracted 
overnight in methanol to remove any contaminants. Serum was transferred using a new glass 
pipet for each sample. The total weight of each pool was determined as the difference in 
weight between the empty bottle and the bottle plus the serum on an AX105 (Mettler 
Toledo, Columbus, OH) balance.
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Analytical Methods.
The sample preparation method was based on the original work by Hovander et al.10 after 
modification and automation conducted in our laboratory.11 The Standard Operating 
Procedure documentation is publicly available.12 Two grams of serum was used for the 
measurements of PBDEs and BB153 randomly assigned to 24 sample batches for analysis; 
each analytical batch contained three quality control and three blank samples prepared with 
bovine serum (Gibco Inc. Grand Island, NY) diluted 1:40 with HPLC grade water (Labsolv 
Scientific Ltd., Tamil Nadu, India). All analytical data were subtracted from the median 
blank. The limits of detection (LODs) were determined as the higher of (1) three times the 
standard deviation of the amount present in blanks or (2) the instrumental LOD defined as 
the injected amount known to produce a gas chromatography/isotope dilution−high-
resolution mass spectrometry signal/noise ratio > 10. The CV of the quality control samples 
made from the standard reference material 195813 was below 10%.
Statistical Methods.
We used SAS (version 9.4; SAS Institute Inc.; Cary, North Carolina) to perform statistical 
analyses. We conducted weighted multiple linear regression to examine the associations 
between the POP biomarkers and several variables (survey cycles (continuous), race (MA, 
NHW, NHB, OTHER for 5 survey periods covering the years 2005 through 2014), sex, age 
(12–19, 20–39, 40–59, and ≥60 years)). For the multiple regression models, we used the 
above variables and all their possible two-way interactions to calculate the adjusted 
geometric mean (AGM) concentrations. Because the distributions of the dependent 
variables’ measurements were skewed to higher values, the dependent variable 
concentrations were log10 transformed in the multiple regression analyses. The final 
regression model included race/ethnicity, sex, and age as categorical main effects; survey 
period (1 through 5) as continuous main effects; and the interaction between the age and 
survey period. We also calculated the relative change in biomarker concentration associated 
with an unit increase in the survey cycle (per 2 years cycle, ng/lipid). For biomarker 
concentrations below the LOD, we imputed a value equal to the LOD divided by the square 
root of 2.14 Statistical significance was set at p < 0.05.
We calculated the median and selected percentiles of total percent body fat by age and sex 
from publicly available data for NHANES 2005/0615 after removing imputed data added to 
the data set (Table S9).
RESULTS
Eleven PBDE congeners (tri- to decaBDE) and BB-153 have been measured in NHANES 
2005/06 through 2013/14. Only congeners with detection frequencies over 60% in all 
demographic groups were considered for the statistical analysis, i.e., BDE28 (90%), BDE47 
(100%), BDE99 (99%), BDE100 (100%), BDE153 (100%), and BB153 (77%). BDE154 
and BDE209 had detection frequencies over 60% only in NHANES 2011/12 and 2013/14; 
only these two surveys were included for BDE154 and BDE209. The overall detection 
frequency in NHANES 2011/12 and 2013/14 for BDE154 and BDE209 was 68 and 95%, 
respectively.
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The AGM, 95% confidence interval (95% CI) and level of significance of the terms above 
when significant (p < 0.05) are given in Table 1 for BDE47 and Tables S1–S7 for BDE28, 
BDE99, BDE100, BDE153, BDE154, BDE209, and BB153. The level of significance for 
pairwise comparisons are also given in Tables 1 and S2–S8.
Change in PBDE Serum Concentration by Survey Period and Subjects Age.
The AGM and 95% CI of the serum concentrations of BDE28, BDE47, BDE99, BDE100, 
BDE153, and BB153 are given by age group and survey period (Figures 1 and S2–S8). The 
general trend is lower concentrations in more recent years with the distinct exception of 
BDE153 in the age groups 40–59 and ≥60 years, where we observed higher serum 
concentrations in more recent survey periods (Figure 1 and Table S2). The percentage 
change by the 2-year survey period in lipid-adjusted AGM serum concentration for BDE28, 
BDE47, BDE99, BDE100, BDE153, and BB153 is shown in Figure 2 and Table 2. All six 
PBDEs encompassing five survey periods decreased in concentration, except BDE153, 
which increased by 12.0% (95% CI 7.1–16.4) and 8.4% (95% CI 2.9–14.1) per the 2- year 
survey period for the age groups 40–59 years and ≥60, respectively. On the other hand, no 
significant change by the 2- year survey period was observed for BDE153 in the age groups 
of 12–19 and 20–39 year olds. Excluding BDE153, we observed larger percentage decreases 
by the 2-year survey period for the age groups of 12–19, 20–39, and ≥60 years compared 
with the age group of 40–59 years (Figure 2 and Table 2).
Concentration Difference by Sex.
The AGM concentrations by sex are given for BDE47, BDE99, BDE100, BDE153, and 
BB153 in Figure 3 and Tables 1 and S2–S8. Males had significantly (p < 0.05) higher lipid 
adjusted serum PBDE concentrations compared with females (range, 7 [BDE28] to 17% 
[BDE99]). BB153 was 40% higher in males compared to females (p < 0.0001).
AGM concentrations of BDE154 and BDE209, based on data for NHANES 2011/12 and 
2013/14, also differed significantly by sex. BDE154 was 16% higher in males than females 
(Table S6). For BDE209, there was a significant interaction term between age and sex 
(Figure 4 and Table S7), where 12–19 year old males had lower concentrations than older 
males, while female concentrations did not vary significantly by age. Males had higher 
serum concentrations at 20–39 (37%), 40–59 (45%), and ≥60 (18%) years than females, and 
there were no significant differences for the 12–19 year olds by sex.
Concentration Difference by Ethnicity/Race.
NHB had 16–20% higher BDE47 concentration (p < 0.01) than MA, NHW, and OTHER 
(Table 1 and Figure S1). BDE99 and BDE100 concentrations were also higher in NHB than 
in other race/ethnic groups (p < 0.01). In the case of BDE153, no statistical differences were 
observed among MA, MHB, and NHW, while the OTHER group had lower serum 
concentrations compared to MA and NHW (p < 0.001).
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DISCUSSION
The fact that five PBDE congeners and BB153 had detection frequencies of 77% and above 
suggests that these POPs continue to be detectable in a large proportion of the U.S. 
population years to decades after discontinuation of their sale and registered use. However, 
the continuous presence of these POPs is not unexpected, considering that PBDEs are 
persistent and still present in upholstered furniture and polyurethane pads under wall−wall 
carpets manufactured before the phase- out.2 Further, because the pad under wall-to-wall 
carpets can also contain recycled polyurethane, PBDEs might have been introduced into 
homes after the phase-out of these compounds. On the other hand, although BB153 has not 
been commercially produced in the United States since the 1970s, its biological half-life, 
estimated to be 11 years,16 can explain the detection of this substance in recently collected 
human serum.
BDE209 was not included in previous publications on NHANES data from our 
laboratory17–19 because of its overall relatively low detection frequency. In recent years, we 
were able to reduce the analytical background with the concomitant decrease in the LOD 
(i.e., to 0.8 ng/g lipid or a factor of 3 lower in NHANES 2011/12 and 2013/14 than in 
previous surveys for a 2-g serum sample). Of interest, the BDE209 serum concentration is 
relatively low compared to other BDEs (e.g., BDE47), even though BDE209 is present at 
much higher (4-fold) concentrations in indoor dust than BDE47.5 This lower serum 
concentration is most likely due to a relative short biological half-life of BDE209, 
corresponding to 2 weeks in humans.20 The biological half-life of lower bromination degree 
BDEs is longer and measured in years; however, these estimates are modeled and not 
directly observed after a substantial reduction in exposure and are hence associated with 
substantial uncertainty and/or bias.21,22
The lower concentration of PBDEs in the age group of 40–59 year vs younger and older 
subjects17–19 has been puzzling. At this point, with data from multiple NHANES cycles, we 
further see that the overall decrease over time in serum PBDEs is lower in the same age 
group (40–59 year olds) for all PBDEs investigated. Further, the hexabrominated congener 
BDE153 is increasing in concentration in the 40–59 year olds and, to a lesser extent, in the 
group of 60 years of age and older. It is not plausible that exposure would have increased for 
the 40–59 year olds but not for other age groups. It is possible that BDE153 could be formed 
from higher bromination degree congeners, e.g., BDE209. However, because we did not 
detect other congeners/degradation products with bromination degrees between BDE209 and 
BDE153 that are not present in technical products, such an explanation is plausible but 
unlikely. Because PBDEs are lipophilic and primarily distribute into the lipid rich tissues of 
the body, a more likely explanation is that increases in body weight with age led to a 
successively larger dilution of PBDEs in an increasingly fat distribution volume (Table S9). 
The total body fat percentage is 19 and 26% higher in the 49–59 year age group vs the 12–
19 year olds for women and men, respectively. Hence, a change in body fat content may 
explain overall lower concentration at an older age but cannot alone explain the increase in 
BDE153 concentration observed in the older age group. A smaller decrease or increase of 
the PBDE concentrations by the survey period among the 40–59 year olds may, on the other 
hand, relate to increased frequency of obesity in 40–59 year olds. With the larger distribution 
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volume of PBDEs in obese persons, a smaller proportion of PBDEs would circulate in serum 
where metabolism and transport to metabolism organs may occur. Therefore, an overall 
increase in the PBDE biological half-life is possible in subjects who are obese, as shown for 
the anxiety drug Diazepam, another lipophilic compound.23 The observed increase in 
BDE153 concentration by the survey period in the age groups of 40–59 and ≥60 years of age 
may hence occur because of an increase in biological half-life resulting in a greater intake 
than elimination in these age groups. Unfortunately, no biological half-lives are known for 
PBDEs, except for BDE183 (3 months) and BDE209 (2 weeks).20
Excluding BDE209, we observed overall lower concentrations from 7 (BDE28) to 27% 
(BDE153) in females vs males. This sex difference is likely related to differences in whole 
body fat content causing differences in distribution volume for men and women for these 
lipophilic compounds. On the other hand, for BDE209, we observed significantly higher 
concentrations in males compared with females for the age groups of 20–39, 40–59, and ≥60 
years; however, the reason for such a sex by age difference is unknown.
We observed higher concentration in NHB subjects for BDE47, BDE99, and BDE100 
compared with MA, NHW, and OTHER, while BDE153 was higher than in the other race/
ethic groups for MHW. These marginal differences may be related, at least in part, to 
occupational exposures, among other causes.
Of interest, BDE47 concentrations in NHANES 2013/14 were about an order of magnitude 
higher than the peak concentrations of BDE47 in the Swedish general population 
(approximately 2 ng/g lipid) in 1998.24 Assuming that the concentration of PBDEs will 
decrease between 5 and 20% every two years in the United States, PBDE concentrations will 
continue to exceed the peak concentrations observed in other parts of the world. Future 
monitoring efforts at the CDC will include analyzing individual serum samples from 
NHANES 2017/18 to track lifestyle factors associated with body burden of PBDEs, such as 
age of primary residence, socioeconomic status, and BMI.
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Figure 1. 
Adjusted geometric mean concentration (ng/g lipid) by age group and survey period for 
BDE47 (A), BDE99 (B), BDE100 (C), and BDE153 (D). Bars indicate 95% CIs.
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Figure 2. 
Percent change in serum concentration by the 2-year survey cycle.
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Figure 3. 
Adjusted geometric mean PBDE concentration (ng/g lipid) by sex.
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Figure 4. 
BDE-209 adjusted geometric mean concentration (ng/g lipid) by age group and sex. Bars 
indicate 95% CI. BDE209 concentration in males 12–19 years are significantly lower than 
other male age groups.
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